Rate Cap for Older Insureds to Mean Higher Health Insurance Costs for Younger
The Obama administration on Friday finalized new consumer safeguards for health insurance that impose tighter restrictions on what insurers can charge older customers, despite industry warnings that...
View ArticleInsurers Balk at High Cost of Specialty Drug
The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing...
View ArticleIn Supreme Court Briefs, Big Business Supports Obamacare Subsidies
The Supreme Court briefs are in, and we can now say that big business backs Obamacare. The justices will hear oral arguments on March 4 in the latest case challenging the Affordable Care Act (ACA). At...
View ArticleInsurers, Drugmakers Tussle Over Drug Copay Caps
The battle over soaring U.S. drug prices is heading for the states. With the price of some treatments topping $100,000, patient groups are pushing for state laws to make sure insurers cover most of the...
View ArticleParrot Bite? In-Law Woes? Whatever the Health Claim, There’s an Insurance Code
There are 70,000 ways to get sick, hurt or mortally injured, and the U.S. is making them official. Last Thursday, U.S. hospitals, doctors and other care providers had to start using internationally...
View ArticleHealth Insurers Working to Improve Provider Network Directories
Some health insurers are hoping to ease headaches that can flare when customers try to confirm whether a doctor is covered in a plan’s network of providers. The trade association America’s Health...
View ArticleStudy: 43% of Insurers’ Prescription Payments Going to Specialty Drugs
The latest study of medicine prices finds U.S. insurers’ spending on expensive prescription drugs nearly quadrupled from 2003 through 2014, when the number of such prescriptions filled tripled....
View ArticleInsurers Lobby for Clarity as Republicans Move to Repeal Obamacare
The largest lobbying group for health insurers has asked U.S. lawmakers weighing the fate of Obamacare to push back the due date for 2018 individual insurance submissions to regulators in hopes of...
View ArticleRate Cap for Older Insureds to Mean Higher Health Insurance Costs for Younger
The Obama administration on Friday finalized new consumer safeguards for health insurance that impose tighter restrictions on what insurers can charge older customers, despite industry warnings that...
View ArticleInsurers Balk at High Cost of Specialty Drug
The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing...
View ArticleIn Supreme Court Briefs, Big Business Supports Obamacare Subsidies
The Supreme Court briefs are in, and we can now say that big business backs Obamacare. The justices will hear oral arguments on March 4 in the latest case challenging the Affordable Care Act (ACA). At...
View ArticleInsurers, Drugmakers Tussle Over Drug Copay Caps
The battle over soaring U.S. drug prices is heading for the states. With the price of some treatments topping $100,000, patient groups are pushing for state laws to make sure insurers cover most of the...
View ArticleParrot Bite? In-Law Woes? Whatever the Health Claim, There’s an Insurance Code
There are 70,000 ways to get sick, hurt or mortally injured, and the U.S. is making them official. Last Thursday, U.S. hospitals, doctors and other care providers had to start using internationally...
View ArticleHealth Insurers Working to Improve Provider Network Directories
Some health insurers are hoping to ease headaches that can flare when customers try to confirm whether a doctor is covered in a plan’s network of providers. The trade association America’s Health...
View ArticleStudy: 43% of Insurers’ Prescription Payments Going to Specialty Drugs
The latest study of medicine prices finds U.S. insurers’ spending on expensive prescription drugs nearly quadrupled from 2003 through 2014, when the number of such prescriptions filled tripled....
View ArticleInsurers Lobby for Clarity as Republicans Move to Repeal Obamacare
The largest lobbying group for health insurers has asked U.S. lawmakers weighing the fate of Obamacare to push back the due date for 2018 individual insurance submissions to regulators in hopes of...
View ArticleInside Big Pharma’s Stealth War on Drug Price Watchdog: Reuters Special Report
As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc., could charge up to...
View Article
